Review| Volume 131, ISSUE 8, P896-901, August 2018

Update in Outpatient General Internal Medicine: Practice-Changing Evidence Published in 2017

Published:February 26, 2018DOI:


      Clinicians are challenged to identify new practice-changing articles in the medical literature. To identify the practice-changing articles published in 2017 most relevant to outpatient general internal medicine, 5 internists reviewed the following sources: 1) titles and abstracts from internal medicine journals with the 7 highest impact factors, including New England Journal of Medicine, Lancet, Journal of the American Medical Association, British Medical Journal, Public Library of Science Medicine, Annals of Internal Medicine, and JAMA Internal Medicine; 2) synopses and syntheses of individual studies, including collections in the American College of Physicians Journal Club, Journal Watch, and Evidence-Based Medicine; 3) databases of synthesis, including Evidence Updates and the Cochrane Library. Inclusion criteria were perceived clinical relevance to outpatient general medicine, potential for practice change, and strength of evidence. This process yielded 140 articles. Clusters of important articles around one topic were considered as a single-candidate series. A modified Delphi method was utilized by the 5 authors to reach consensus on 7 topics to highlight and appraise from the 2017 literature


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Mas J.L.
        • Derumeaux G.
        • Guillon B.
        • et al.
        Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke.
        N Engl J Med. 2017; 377: 1011-1021
        • Saver J.L.
        • Carroll J.D.
        • Thaler D.E.
        • et al.
        Long-term outcomes of patent foramen ovale closure or medical therapy after stroke.
        N Engl J Med. 2017; 377: 1022-1032
        • Sondergaard L.
        • Kasner S.E.
        • Rhodes J.F.
        • et al.
        Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke.
        N Engl J Med. 2017; 377: 1033-1042
        • Messe S.R.
        • Gronseth G.
        • Kent D.M.
        • et al.
        Practice advisory: Recurrent stroke with patent foramen ovale (update of practice parameter): Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
        Neurology. 2016; 87: 815-821
        • Carroll J.D.
        • Saver J.L.
        • Thaler D.E.
        • et al.
        Closure of patent foramen ovale versus medical therapy after cryptogenic stroke.
        N Engl J Med. 2013; 368: 1092-1100
        • Al-Lamee R.
        • Thompson D.
        • Dehbi H.-M.
        • et al.
        Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial.
        Lancet. 2018; 391: 31-40
        • Boden W.E.
        • O'Rourke R.A.
        • Teo K.K.
        • et al.
        Optimal medical therapy with or without PCI for stable coronary disease.
        N Engl J Med. 2007; 356: 1503-1516
        • Borden W.B.
        • Redberg R.F.
        • Mushlin A.I.
        • Dai D.
        • Kaltenbach L.A.
        • Spertus J.A.
        Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention.
        JAMA. 2011; 305: 1882-1889
        • Grupping K.
        • Campora L.
        • Douha M.
        • et al.
        Immunogenicity and safety of the HZ/su adjuvanted herpes zoster subunit vaccine in adults previously vaccinated with a live attenuated herpes zoster vaccine.
        J Infect Dis. 2017; 216: 1343-1351
        • Harpaz R.
        • Ortega-Sanchez I.R.
        • Seward J.F.
        Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).
        MMWR Recomm Rep. 2008; 57 (quiz CE32-34): 1-30
        • Oxman M.N.
        • Levin M.J.
        • Johnson G.R.
        • et al.
        A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
        N Engl J Med. 2005; 352: 2271-2284
        • Morrison V.A.
        • Johnson G.R.
        • Schmader K.E.
        • et al.
        Long-term persistence of zoster vaccine efficacy.
        Clin Infect Dis. 2015; 60: 900-909
        • Chlibek R.
        • Pauksens K.
        • Rombo L.
        • et al.
        Long-term immunogenicity and safety of an investigational herpes zoster subunit vaccine in older adults.
        Vaccine. 2016; 34: 863-868
        • Cunningham A.L.
        • Lal H.
        • Kovac M.
        • et al.
        Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older.
        N Engl J Med. 2016; 375: 1019-1032
        • Lal H.
        • Cunningham A.L.
        • Godeaux O.
        • et al.
        Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults.
        N Engl J Med. 2015; 372: 2087-2096
        • Centers for Disease Control and Prevention
        Shingles (Herpes Zoster).
        (Available at:)
        Date accessed: December 19, 2017
        • Halpern J.A.
        • Chughtai B.
        • Ghomrawi H.
        Cost-effectiveness of common diagnostic approaches for evaluation of asymptomatic microscopic hematuria.
        JAMA Intern Med. 2017; 177: 800-807
        • Loo R.K.
        • Lieberman S.F.
        • Slezak J.M.
        • et al.
        Stratifying risk of urinary tract malignant tumors in patients with asymptomatic microscopic hematuria.
        Mayo Clin Proc. 2013; 88: 129-138
        • Mohr D.N.
        • Offord K.P.
        • Owen R.A.
        • Melton 3rd., L.J.
        Asymptomatic microhematuria and urologic disease. A population-based study.
        JAMA. 1986; 256: 224-229
        • Nielsen M.
        • Qaseem A.
        • High Value Care Task Force of the American College of Physicians
        Hematuria as a marker of occult urinary tract cancer: advice for high-value care from the American College of Physicians.
        Ann Intern Med. 2016; 164: 488-497
        • Davis R.
        • Jones J.S.
        • Barocas D.A.
        • et al.
        Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline.
        J Urol. 2012; 188: 2473-2481
        • Wollin T.
        • Laroche B.
        • Psooy K.
        Canadian guidelines for the management of asymptomatic microscopic hematuria in adults.
        Can Urol Assoc J. 2009; 3: 77-80
        • van der Molen A.J.
        • Hovius M.C.
        Hematuria: a problem-based imaging algorithm illustrating the recent Dutch guidelines on hematuria.
        AJR Am J Roentgenol. 2012; 198: 1256-1265
        • Whelton P.K.
        • Carey R.M.
        • Aronow W.S.
        • et al.
        2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines [e-pub ahead of print].
        J Am Coll Cardiol. 2017;
        • James P.A.
        • Oparil S.
        • Carter B.L.
        • et al.
        2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).
        JAMA. 2014; 311: 507-520
        • Group S.R.
        • Wright Jr, J.T.
        • Williamson J.D.
        • et al.
        A randomized trial of intensive versus standard blood-pressure control.
        N Engl J Med. 2015; 373: 2103-2116
        • Li L.
        • Geraghty O.C.
        • Mehta Z.
        • Rothwell P.M.
        • Oxford Vascular Study.
        Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study.
        Lancet. 2017; 390: 490-499
        • Kernan W.N.
        • Ovbiagele B.
        • Black H.R.
        • et al.
        Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.
        Stroke. 2014; 45: 2160-2236
        • Levine G.N.
        • Bates E.R.
        • Bittl J.A.
        • et al.
        2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
        Circulation. 2016; 134: e123-e155
        • Bhatt D.L.
        • Scheiman J.
        • Abraham N.S.
        • et al.
        ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.
        Circulation. 2008; 118: 1894-1909
        • Bally M.
        • Dendukuri N.
        • Rich B.
        • et al.
        Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data.
        BMJ. 2017; 357: j1909
        • Nissen S.E.
        • Yeomans N.D.
        • Solomon D.H.
        • et al.
        Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis.
        N Engl J Med. 2016; 375: 2519-2529
        • Gore M.
        • Sadosky A.
        • Leslie D.
        • Tai K.S.
        • Seleznick M.
        Patterns of therapy switching, augmentation, and discontinuation after initiation of treatment with select medications in patients with osteoarthritis.
        Clin Ther. 2011; 33: 1914-1931
        • Langman M.
        • Kahler K.A.H.
        • Kong S.X.
        • et al.
        Drug switching patterns among patients taking non-steroidal anti-inflammatory drugs: a retrospective cohort study of a general practitioners database in the United Kingdom.
        Pharmacoepidemiol Drug Saf. 2001; 10: 517-524